TCT 702: Shockwave Intravascular Lithotripsy in Calcified Common Femoral Lesions in Patients With Peripheral Arterial Disease: 30-Day Health Status Outcomes From CRUSH-PAD Trial

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:

• Consultant Fee/Honoraria/Speaker’s Bureau - Abbott Vascular; Terumo Medical Corporation; Cook Medical
• Grant Support/Research Contract - J&J; Abbott; Merck/Schering Plough